Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

boehringer ingelheim (schweiz) gmbh - nintedanibum - capsule molli - nintedanibum 150 mg ut nintedanibi esilas, triglycerida media, adeps solidus, lecithinum, kapselhülle: gelatina, glycerolum (85 per cento), e 171, e 172 (rubrum), e 172 (flavum), drucktinte: lacca, propylenglycolum, e 172 (nigrum), excipiens pro capsula. - idiopathische lungenfibrose, interstitielle lungenerkrankungen - synthetika